A citation-based method for searching scientific literature

Ilio Vitale, Efrat Shema, Sherene Loi, Lorenzo Galluzzi. Nat Med 2021
Times Cited: 43







List of co-cited articles
267 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Mitochondrial DNA drives abscopal responses to radiation that are inhibited by autophagy.
Takahiro Yamazaki, Alexander Kirchmair, Ai Sato, Aitziber Buqué, Marissa Rybstein, Giulia Petroni, Norma Bloy, Francesca Finotello, Lena Stafford, Esther Navarro Manzano,[...]. Nat Immunol 2020
68
23

Immunomodulation by targeted anticancer agents.
Giulia Petroni, Aitziber Buqué, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi. Cancer Cell 2021
30
30

Consensus guidelines for the definition, detection and interpretation of immunogenic cell death.
Lorenzo Galluzzi, Ilio Vitale, Sarah Warren, Sandy Adjemian, Patrizia Agostinis, Aitziber Buqué Martinez, Timothy A Chan, George Coukos, Sandra Demaria, Eric Deutsch,[...]. J Immunother Cancer 2020
171
16

Immunological impact of cell death signaling driven by radiation on the tumor microenvironment.
Maria Esperanza Rodriguez-Ruiz, Ilio Vitale, Kevin J Harrington, Ignacio Melero, Lorenzo Galluzzi. Nat Immunol 2020
77
16

Hallmarks of cancer: the next generation.
Douglas Hanahan, Robert A Weinberg. Cell 2011
13

The autophagic network and cancer.
Marissa D Rybstein, José Manuel Bravo-San Pedro, Guido Kroemer, Lorenzo Galluzzi. Nat Cell Biol 2018
163
11

Understanding the tumor immune microenvironment (TIME) for effective therapy.
Mikhail Binnewies, Edward W Roberts, Kelly Kersten, Vincent Chan, Douglas F Fearon, Miriam Merad, Lisa M Coussens, Dmitry I Gabrilovich, Suzanne Ostrand-Rosenberg, Catherine C Hedrick,[...]. Nat Med 2018
11

Oncology meets immunology: the cancer-immunity cycle.
Daniel S Chen, Ira Mellman. Immunity 2013
11

Apoptotic caspases inhibit abscopal responses to radiation and identify a new prognostic biomarker for breast cancer patients.
Maria Esperanza Rodriguez-Ruiz, Aitziber Buqué, Michal Hensler, Jonathan Chen, Norma Bloy, Giulia Petroni, Ai Sato, Takahiro Yamazaki, Jitka Fucikova, Lorenzo Galluzzi. Oncoimmunology 2019
49
11

The consensus molecular subtypes of colorectal cancer.
Justin Guinney, Rodrigo Dienstmann, Xin Wang, Aurélien de Reyniès, Andreas Schlicker, Charlotte Soneson, Laetitia Marisa, Paul Roepman, Gift Nyamundanda, Paolo Angelino,[...]. Nat Med 2015
9

Cancer Statistics, 2021.
Rebecca L Siegel, Kimberly D Miller, Hannah E Fuchs, Ahmedin Jemal. CA Cancer J Clin 2021
9

The hallmarks of successful anticancer immunotherapy.
Lorenzo Galluzzi, Timothy A Chan, Guido Kroemer, Jedd D Wolchok, Alejandro López-Soto. Sci Transl Med 2018
221
9

Cancer Immunosurveillance by T Cells.
Samhita Rao, Karim Gharib, Arnold Han. Int Rev Cell Mol Biol 2019
32
12

Calreticulin arms NK cells against leukemia.
Jitka Fucikova, Justin P Kline, Lorenzo Galluzzi, Radek Spisek. Oncoimmunology 2019
10
40

Radiotherapy Delivered before CDK4/6 Inhibitors Mediates Superior Therapeutic Effects in ER+ Breast Cancer.
Giulia Petroni, Aitziber Buqué, Takahiro Yamazaki, Norma Bloy, Maurizio Di Liberto, Selina Chen-Kiang, Silvia C Formenti, Lorenzo Galluzzi. Clin Cancer Res 2021
10
40

DNA Damage in Stem Cells.
Ilio Vitale, Gwenola Manic, Ruggero De Maria, Guido Kroemer, Lorenzo Galluzzi. Mol Cell 2017
140
6

Cancer stem cells revisited.
Eduard Batlle, Hans Clevers. Nat Med 2017
918
6

Control of replication stress and mitosis in colorectal cancer stem cells through the interplay of PARP1, MRE11 and RAD51.
Gwenola Manic, Martina Musella, Francesca Corradi, Antonella Sistigu, Sara Vitale, Sara Soliman Abdel Rehim, Luca Mattiello, Eva Malacaria, Claudia Galassi, Michele Signore,[...]. Cell Death Differ 2021
8
37

Ca2+ Fluxes and Cancer.
Saverio Marchi, Carlotta Giorgi, Lorenzo Galluzzi, Paolo Pinton. Mol Cell 2020
41
7

Mitochondria-associated membranes (MAMs) and inflammation.
Sonia Missiroli, Simone Patergnani, Natascia Caroccia, Gaia Pedriali, Mariasole Perrone, Maurizio Previati, Mariusz R Wieckowski, Carlotta Giorgi. Cell Death Dis 2018
87
6

Targeting mitochondria for cardiovascular disorders: therapeutic potential and obstacles.
Massimo Bonora, Mariusz R Wieckowski, David A Sinclair, Guido Kroemer, Paolo Pinton, Lorenzo Galluzzi. Nat Rev Cardiol 2019
90
6

The calcium-cancer signalling nexus.
Gregory R Monteith, Natalia Prevarskaya, Sarah J Roberts-Thomson. Nat Rev Cancer 2017
209
6

Akt-mediated phosphorylation of MICU1 regulates mitochondrial Ca2+ levels and tumor growth.
Saverio Marchi, Mariangela Corricelli, Alessio Branchini, Veronica Angela Maria Vitto, Sonia Missiroli, Giampaolo Morciano, Mariasole Perrone, Mattia Ferrarese, Carlotta Giorgi, Mirko Pinotti,[...]. EMBO J 2019
48
6

Perturbed mitochondrial Ca2+ signals as causes or consequences of mitophagy induction.
Alessandro Rimessi, Massimo Bonora, Saverio Marchi, Simone Patergnani, Carlo M T Marobbio, Francesco M Lasorsa, Paolo Pinton. Autophagy 2013
56
6

Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018.
Lorenzo Galluzzi, Ilio Vitale, Stuart A Aaronson, John M Abrams, Dieter Adam, Patrizia Agostinis, Emad S Alnemri, Lucia Altucci, Ivano Amelio, David W Andrews,[...]. Cell Death Differ 2018
6

Mitotic catastrophe: a mechanism for avoiding genomic instability.
Ilio Vitale, Lorenzo Galluzzi, Maria Castedo, Guido Kroemer. Nat Rev Mol Cell Biol 2011
505
6

Single-Cell Transcriptome Analysis Reveals Disease-Defining T-cell Subsets in the Tumor Microenvironment of Classic Hodgkin Lymphoma.
Tomohiro Aoki, Lauren C Chong, Katsuyoshi Takata, Katy Milne, Monirath Hav, Anthony Colombo, Elizabeth A Chavez, Michael Nissen, Xuehai Wang, Tomoko Miyata-Takata,[...]. Cancer Discov 2020
56
6

Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response.
Peng Jiang, Shengqing Gu, Deng Pan, Jingxin Fu, Avinash Sahu, Xihao Hu, Ziyi Li, Nicole Traugh, Xia Bu, Bo Li,[...]. Nat Med 2018
518
6

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
6

Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma.
Jesse M Zaretsky, Angel Garcia-Diaz, Daniel S Shin, Helena Escuin-Ordinas, Willy Hugo, Siwen Hu-Lieskovan, Davis Y Torrejon, Gabriel Abril-Rodriguez, Salemiz Sandoval, Lucas Barthly,[...]. N Engl J Med 2016
6

Combination cancer immunotherapies tailored to the tumour microenvironment.
Mark J Smyth, Shin Foong Ngiow, Antoni Ribas, Michele W L Teng. Nat Rev Clin Oncol 2016
481
6

Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq.
Itay Tirosh, Benjamin Izar, Sanjay M Prakadan, Marc H Wadsworth, Daniel Treacy, John J Trombetta, Asaf Rotem, Christopher Rodman, Christine Lian, George Murphy,[...]. Science 2016
6

ATP and cancer immunosurveillance.
Oliver Kepp, Lucillia Bezu, Takahiro Yamazaki, Francesco Di Virgilio, Mark J Smyth, Guido Kroemer, Lorenzo Galluzzi. EMBO J 2021
7
42

Interplay between dendritic cells and cancer cells.
Jan Martinek, Te-Chia Wu, Diana Cadena, Jacques Banchereau, Karolina Palucka. Int Rev Cell Mol Biol 2019
21
14

Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors.
Lorenzo Galluzzi, Juliette Humeau, Aitziber Buqué, Laurence Zitvogel, Guido Kroemer. Nat Rev Clin Oncol 2020
110
6

The immune contexture in cancer prognosis and treatment.
Wolf H Fridman, Laurence Zitvogel, Catherine Sautès-Fridman, Guido Kroemer. Nat Rev Clin Oncol 2017
762
6

Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer.
Aitziber Buqué, Norma Bloy, Maria Perez-Lanzón, Kristina Iribarren, Juliette Humeau, Jonathan G Pol, Sarah Levesque, Laura Mondragon, Takahiro Yamazaki, Ai Sato,[...]. Nat Commun 2020
31
9

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Hyuna Sung, Jacques Ferlay, Rebecca L Siegel, Mathieu Laversanne, Isabelle Soerjomataram, Ahmedin Jemal, Freddie Bray. CA Cancer J Clin 2021
6


Applying high-dimensional single-cell technologies to the analysis of cancer immunotherapy.
Satyen H Gohil, J Bryan Iorgulescu, David A Braun, Derin B Keskin, Kenneth J Livak. Nat Rev Clin Oncol 2021
24
12

Tertiary lymphoid structures in the era of cancer immunotherapy.
Catherine Sautès-Fridman, Florent Petitprez, Julien Calderaro, Wolf Herman Fridman. Nat Rev Cancer 2019
295
6


Anti-tumor immunity influences cancer cell reliance upon ATG7.
Michael D Arensman, Xiaoran S Yang, Wenyan Zhong, Stephanie Bisulco, Erik Upeslacis, Edward C Rosfjord, Shibing Deng, Robert T Abraham, Christina H Eng. Oncoimmunology 2020
8
37

Links between cancer metabolism and cisplatin resistance.
Veronica Cocetta, Eugenio Ragazzi, Monica Montopoli. Int Rev Cell Mol Biol 2020
11
27

Molecular platforms for targeted drug delivery.
Katia Maso, Antonella Grigoletto, María J Vicent, Gianfranco Pasut. Int Rev Cell Mol Biol 2019
15
20

Endoplasmic reticulum stress in the cellular release of damage-associated molecular patterns.
Alejandra Wu Chuang, Oliver Kepp, Guido Kroemer, Lucillia Bezu. Int Rev Cell Mol Biol 2020
6
50

Crosstalk between apoptosis and autophagy signaling pathways.
W Douglas Fairlie, Sharon Tran, Erinna F Lee. Int Rev Cell Mol Biol 2020
14
21

Type 3 IP3 receptors: The chameleon in cancer.
Nicolas Rosa, Flore Sneyers, Jan B Parys, Geert Bultynck. Int Rev Cell Mol Biol 2020
10
30

Redox signaling in the pathogenesis of human disease and the regulatory role of autophagy.
Shazib Pervaiz, Gregory L Bellot, Antoinette Lemoine, Catherine Brenner. Int Rev Cell Mol Biol 2020
6
50

The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy.
Daniela Bruni, Helen K Angell, Jérôme Galon. Nat Rev Cancer 2020
167
6


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.